Comorbidity of atherosclerotic diseases in COPD patients.

V. Nevzorova (Vladivostok, Russian Federation), N. Zakharchuk (Vladivostok, Russian Federation), E. Kondrashova (Vladivostok, Russian Federation), E. Gonchar (Vladivostok, Russian Federation)

Source: International Congress 2018 – Cardiovascular morbidities in COPD
Session: Cardiovascular morbidities in COPD
Session type: Thematic Poster
Number: 734
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Nevzorova (Vladivostok, Russian Federation), N. Zakharchuk (Vladivostok, Russian Federation), E. Kondrashova (Vladivostok, Russian Federation), E. Gonchar (Vladivostok, Russian Federation). Comorbidity of atherosclerotic diseases in COPD patients.. 734

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comorbidity and some markers of cardiovascular disorders in disabled COPD patients
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012


Comorbidity in patients with COPD in Russia
Source: Annual Congress 2013 –COPD treatment
Year: 2013


Lipid profile in COPD patients with coronary artery disease comorbidity
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013

Comorbidity in patients with IHD - the prevalence of COPD
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016

Prevalence of COPD in vascular diseases
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015


Comorbidity and some issues of cardiovascular disorders in disabled asthma patients
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015


Comorbidity: a distinctive feature of elderly respiratory patients
Source: Eur Respir Mon; 2009: 43: 205–216
Year: 2009

Comorbidities in COPD patients are not associated to higher disease severity
Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation
Year: 2011


Asthma and COPD in patients with coronary artery disease - The unmet demands
Source: International Congress 2016 – Best abstracts in asthma and COPD
Year: 2016

Prevalence of COPD and comorbidity
Source: Eur Respir Mon 2013; 59: 1-12
Year: 2013


Renal impairment a neglected comorbidity in patients with COPD
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016


Prevalence of undiagnosed COPD in patients with established cardiovascular diseases
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010


Cardiovascular comorbidity in severe COPD patients
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort
Source: International Congress 2014 – Clinical presentations
Year: 2014


Comorbit coronary artery disease is related to worse outcomes in patients hospitalised for COPD exacerbation
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016


Predictors of coronary heart disease in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015


Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015

Venous thromboembolic (VTE) disease in people with chronic obstructive pulmonary disease (COPD): A matched case-control study
Source: International Congress 2015 – New observations in respiratory epidemiology
Year: 2015


Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


The cardiovascular  comorbidity and the risk of stroke by means of CHADS2- VASc scale  in patients with chronic obstructive pulmonary disease.
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017